'Plan B' on the way to shelves sans limits
WASHINGTON — The morning-after pill is going over-the-counter.
The Food and Drug Administration on Thursday approved unrestricted sales of Plan B One-Step, lifting all age limits on the emergency contraceptive.
The move occurred a week after the Obama administration ended months of back-and-forth legal battles by promising a federal judge that it would take that step. Women's health advocates had pushed for easier access to next-day birth control for more than a decade.
“Over-the-counter access to emergency contraceptive products has the potential to further decrease the rate of unintended pregnancies in the United States,” FDA drug chief Dr. Janet Woodcock said in a statement announcing the approval.
It wasn't clear how quickly Plan B One-Step would move from behind pharmacy counters to sit on pharmacy shelves. Until now, customers could buy that morning-after pill and competing generic versions without a prescription only if they proved to a pharmacist that they were 17 or older.
The FDA said the product must be repackaged to reflect the change;. Maker Teva Women's Health didn't immediately respond.
The agency, though, has not lifted age limits on competing generics.
The morning-after pill contains a higher dose of the hormone in regular birth-control pills. Taking it within 72 hours of rape, condom failure or just forgetting traditional contraception can cut the chances of pregnancy by up to 89 percent.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Fewer adults smoking, U.S. survey finds
- Surge in small drones making airline pilots nervous
- Liberal Supreme Court Justice Ginsburg has stent placed in heart artery
- Fissures begin to emerge among Dems
- Boston airport’s ‘naked man’ remains behind bars
- Rookie Cleveland police officer acted within 2 seconds to shoot 12-year-old boy
- Obama’s immigration actions neglect business pleas
- In Ferguson, demonstrations over black youth’s slaying by police officer peter out
- House ethics panel defers campaign finance investigation of New York Rep. Grimm
- Test vaccine to fight Ebola promising
- Obama administration announces plan to limit smog-forming ozone